Patient-assessed versus physician-assessed disease severity and outcome in patients with nonspecific pain associated with major depressive disorder

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 11, Issue 1, 2009, Pages 8-15

  Demyttenaere, Koen ^a   Desaiah, Durisala ^a   Petit, Claude ^a   Croenlein, Jens ^a   Brecht, Stephan ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; PLACEBO;

AGE DISTRIBUTION; ANXIETY; ARTICLE; BRIEF PAIN INVENTORY; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; OBSERVER VARIATION; OBSESSIVE COMPULSIVE DISORDER; OUTCOME ASSESSMENT; PAIN; PARALLEL DESIGN; PATIENT ASSESSMENT; PHYSICIAN; POST HOC ANALYSIS; PREDICTOR VARIABLE; RANDOMIZED CONTROLLED TRIAL; SYMPTOM CHECKLIST 90;

EID: 77952128909     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/pcc.08m00670     Document Type: Article

References (23)

1. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
2. Lehman AF, Babigian HM, Reed SK. The epidemiology of treatment for chronic and nonchronic mental disorders. J Nerv Ment Dis 1984; 172:658-666
3. Beneke M, Rasmus W. Clinical Global Impressions (ECDEU): some critical comments. Pharmacopsychiatry 1991;25(4):171-176
4. Leon AC, Shear MK, Klerman GL, et al. A comparison of symptom determinants of patient and clinician global ratings in patients with panic disorder and depression. J Clin Psychopharmacol 1993;13: 327-331
5. Zaider TI, Heimberg RG, Fresco DM, et al. Evaluation of the Clinical Global Impressions scale among individuals with social anxiety disorder. Psychol Med 2003;33:611-622
6. Demyttenaere K, Bonnewyn A, Bruffaerts R et al. Comorbid painful physical symptoms and depression: prevalence, work loss, and help seeking. J Affect Disord 2006;92(2-3):185-193
7. Demyttenaere K, Bonnewyn A, Bruffaerts R et al. Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD) [published online ahead of print March 7, 2008]. J Affect Disord 2008;110(1-2):84-93. doi:10.1016/j.jad.2008.01.011
8. Demyttenaere K, De Fruyt J. Getting what you ask for: on the selectivity of depression rating scales. Psychother Psychosom 2003;72(2): 61-70
9. Brecht S, Courtecuisse C, Debieuvre C, et al. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial. J Clin Psychiatry 2007;68(11):1707-1716
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
11. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22-33
12. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap 1994;23:129-138
13. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389
14. SCL-90 Self-Report Symptom Inventory. In: Guy W, ed. ECDEU Assessment Manual for Psychopharmacology, revised edition. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:314-330
15. Derogatis LR, Lipman RS, Rickels K, et al. The Hopkins Symptom Checklist (HSCL): a measure of primary symptom dimensions. Mod Probl Pharmacopsychiatry 1974;7:79-110
16. Derogatis LR, Lipman RS, Rickels K, et al. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci 1974;19:1-15
17. Hartford J, Kornstein S, Liebowitz M, et al. Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo- and active-controlled trial. Int Clin Psychopharmacol 2007;22:167-174
18. Allgulander C, Hartford J, Russell J, et al. Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials. Curr Med Res Opin 2007;23:1245-1252
19. Leonard BE, Healy D. Differential Effects of Antidepressants. London, England: Martin Dunitz; 1999
20. Enns MW, Larsen DK, Cox BJ. Discrepancies between self and observer ratings of depression: the relationship to demographic, clinical, and personality variables. J Affect Disord 2000;60(1):33-41
21. Paykel ES, Prusoff BA. Relationships between personality dimensions: neuroticism and extraversion against obsessive, hysterical and oral personality. Br J Soc Clin Psychol 1973;12:309-318
22. Duberstein PR, Heisel MJ. Personality traits and the reporting of affective disorder symptoms in depressed patients. J Affect Disord 2007;103: 165-171
23. Tylee A, Walters P. Underrecognition of anxiety and mood disorders in primary care: why does the problem exist and what can be done? J Clin Psychiatry 2007;68(suppl 2):27-30